References
- Comstock CH, Malone FD, Ball RH, Nyberg DA, Saade GR, Berkowitz RL . 2006. Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening? American Journal of Obstetrics and Gynecology 195:843–847.
- Miron P, Côté YP, Lambert J. 2009. Nuchal translucency thresholds in prenatal screening for Down syndrome and trisomy 18. Journal of Obstetrics and Gynaecology Canada 31:227–235.
- Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. 1992. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. British Medical Journal 304:867–869.
- Schuchter K, Wald N, Hackshaw AK, Hafner E, Liebhart E. 1998. The distribution of nuchal translucency at 10–13 weeks of pregnancy. Prenatal Diagnosis 18:281–286.
- Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. 1998. UK multicenter project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation. Lancet 352:343–346.
- Spencer K. 2007. Aneuploidy screening in the first trimester. American Journal of Medical Genetics 145C:18–32.
- Theodoropoulos P, Lolis D, Papageorgiou C, Papaioannou S, Plachouras N, Makrydimas G. 1998. Evaluation of first trimester screening by fetal nuchal translucency and maternal age. Prenatal Diagnosis 18:133–137.